Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)
Health Care Science · 2022
DOI: 10.1002/hcs2.1 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Health Care Science, 2022. Verfasst von Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022. Die Arbeit wurde bisher 44-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To further improve the diagnosis and treatment of COVID‐19, China National Health Commission and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID‐19 Patients (Trial Version 8) and developed the Diagnosis and Treatment Protocol for COVID‐19 Patients (Trial Version 9), summarizing the etiological characteristics, epidemiological characteristics, pathological changes, clinical features, diagnosis, clinical classification, population with high risk of severe/critical illnesses, early warning predictors for severe/critical illnesses, differential diagnosis, case identification and reporting, treatment, nursing, discharge criteria and precautions after discharge, patient transfer, control of nosocomial infection in medical institutions, and disease prevention.
Schlagwörter
Stichwörter der Autor:innen
Zitieren
APA
Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022 (2022). Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9). Health Care Science. https://doi.org/10.1002/hcs2.1
Vancouver
Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022. Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9). Health Care Science. 2022. doi:10.1002/hcs2.1
BibTeX
@article{ReleasedbyNationalHealthCommissionNationalAdministrationofTraditionalChineseMedicineonMarch2022,
author = {Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022, Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022},
title = {Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)},
journal = {Health Care Science},
year = {2022},
doi = {10.1002/hcs2.1}
}
EUVIMED